# Role of Eosinophil in Fibrogenesis of Systemic Sclerosis

> **NCT03816189** · — · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 70 (actual)

## Conditions studied

- Systemic Sclerosis
- Systemic Scleroderma

## Interventions

- **DIAGNOSTIC_TEST:** Blood test
- **DIAGNOSTIC_TEST:** Skin biopsies

## Key facts

- **NCT ID:** NCT03816189
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-03
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03816189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03816189, "Role of Eosinophil in Fibrogenesis of Systemic Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03816189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*